Skip to search formSkip to main contentSkip to account menu

alicaforsen

National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Antisense OligonucleotidesGastrointestinal AgentsImmunosuppressive AgentsPhosphorothioate Oligonucleotides

Narrower (1)

ISIS 2302

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Second-Generation Compounds Advance : Phase 2 a Biomarker Trial of ISIS 104838 in Patients with Rheumatoid Arthritis
  • 2018
  • Corpus ID: 53576237
CARLSBAD, Calif., Oct. 27 /PRNewswire-FirstCall/ -Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced positive data from… 
2002
2002
INFLAMMATORY BOWEL DISEASE Double blind , placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide , alicaforsen ( ISIS 2302…
Background and aims: To evaluate the safety and efficacy of the intercellular adhesion molecule 1 (ICAM-1) antisense…